Our finding that modulating the SIRT2 levels causes changes in the nuclear envelope morphology that are also observed in Parkinson's disease provides an additional insight into the mechanism of SIRT2-mediated neurodegeneration. This evidence concerns the gene SIRT2 and Parkinson disease.